Detectable HIV-1 in semen in individuals with very low blood viral loads.


Journal

Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645

Informations de publication

Date de publication:
05 03 2020
Historique:
received: 12 12 2019
accepted: 20 02 2020
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 11 2 2021
Statut: epublish

Résumé

Several reports indicate that a portion (5-10%) of men living with HIV-1 intermittently shed HIV-1 RNA into seminal plasma while on long term effective antiretroviral therapy (ART). This is highly suggestive of an HIV-1 reservoir in the male genital tract. However, the status of this reservoir in men living with HIV-1 who are not under treatment is underexplored and has implications for understanding the origins and evolution of the reservoir. Forty-three HIV-1 positive, antiretroviral therapy naïve study participants attending a men's health clinic were studied. Semen viral loads and blood viral loads were generally correlated, with semen viral loads generally detected in individuals with blood viral loads > 10,000 cp/ml. However, we found 1 individual with undetectable viral loads (<20cp/ml) and 2 individuals with very low blood viral load (97 and 333cp/ml), but with detectable HIV-1 in semen (485-1157 copies/semen sample). Blood viral loads in the first individual were undetectable when tested three times over the prior 5 years. Semen HIV-1 viral loads are usually related to blood viral loads, as we confirm. Nonetheless, this was not true in a substantial minority of individuals suggesting unexpectedly high levels of replication in the male genital tract in a few individuals, despite otherwise effective immune control. This may reflect establishment of a local reservoir of HIV-1 populations.

Sections du résumé

BACKGROUND
Several reports indicate that a portion (5-10%) of men living with HIV-1 intermittently shed HIV-1 RNA into seminal plasma while on long term effective antiretroviral therapy (ART). This is highly suggestive of an HIV-1 reservoir in the male genital tract. However, the status of this reservoir in men living with HIV-1 who are not under treatment is underexplored and has implications for understanding the origins and evolution of the reservoir.
FINDING
Forty-three HIV-1 positive, antiretroviral therapy naïve study participants attending a men's health clinic were studied. Semen viral loads and blood viral loads were generally correlated, with semen viral loads generally detected in individuals with blood viral loads > 10,000 cp/ml. However, we found 1 individual with undetectable viral loads (<20cp/ml) and 2 individuals with very low blood viral load (97 and 333cp/ml), but with detectable HIV-1 in semen (485-1157 copies/semen sample). Blood viral loads in the first individual were undetectable when tested three times over the prior 5 years.
CONCLUSIONS
Semen HIV-1 viral loads are usually related to blood viral loads, as we confirm. Nonetheless, this was not true in a substantial minority of individuals suggesting unexpectedly high levels of replication in the male genital tract in a few individuals, despite otherwise effective immune control. This may reflect establishment of a local reservoir of HIV-1 populations.

Identifiants

pubmed: 32138741
doi: 10.1186/s12985-020-01300-6
pii: 10.1186/s12985-020-01300-6
pmc: PMC7059658
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

29

Références

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):275-81
pubmed: 23274933
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Clin Infect Dis. 2014 Jun;58(12):1763-70
pubmed: 24647014
Clin Infect Dis. 2019 Oct 30;69(10):1789-1796
pubmed: 30615106
AIDS. 1996 Dec;10(14):F51-6
pubmed: 8970677
Nat Microbiol. 2019 Apr;4(4):633-644
pubmed: 30718846
J Virol. 2015 May;89(10):5264-75
pubmed: 25673728
Cell. 2013 Oct 24;155(3):540-51
pubmed: 24243014
S Afr Med J. 2017 Nov 27;107(12):1116-1120
pubmed: 29262967
J Reprod Immunol. 1998 Dec;41(1-2):27-40
pubmed: 10213299
AIDS. 1999 Jul 30;13(11):1415-7
pubmed: 10449298
Sex Transm Dis. 2008 Jan;35(1):55-60
pubmed: 18217225
JAMA. 2019 Feb 5;321(5):451-452
pubmed: 30629090
AIDS. 2012 May 15;26(8):971-5
pubmed: 22382146
J Infect Dis. 2016 Jul 15;214(2):212-5
pubmed: 27053765
AIDS. 1999 May 7;13(7):823-31
pubmed: 10357382
J Infect Dis. 2014 Apr 15;209(8):1174-84
pubmed: 24273175
J Antimicrob Chemother. 2016 Nov;71(11):3202-3205
pubmed: 27432601
PLoS Pathog. 2018 Jan 18;14(1):e1006754
pubmed: 29346424
J Infect Dis. 2000 May;181(5):1622-8
pubmed: 10783117
Sex Transm Infect. 1999 Aug;75(4):261-3
pubmed: 10615314
Curr Opin HIV AIDS. 2018 Sep;13(5):395-401
pubmed: 29847350
PLoS One. 2017 Aug 16;12(8):e0183376
pubmed: 28813503
Nat Rev Microbiol. 2015 Jul;13(7):414-25
pubmed: 26052661
J Virol. 1997 Aug;71(8):6271-5
pubmed: 9223532
Curr Opin HIV AIDS. 2010 Jul;5(4):335-43
pubmed: 20543610
J Clin Microbiol. 2000 Apr;38(4):1414-8
pubmed: 10747117
Clin Infect Dis. 2013 Aug;57(3):441-7
pubmed: 23595831
Retrovirology. 2017 Mar 23;14(1):22
pubmed: 28335782

Auteurs

Samuel Mundia Kariuki (SM)

Division of Immunology, Department of Pathology, University of Cape Town, Anzio Rd, Observatory, Cape Town, 7925, South Africa.
International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa.
Department of Biological Sciences, School of Science, University of Eldoret, Eldoret, Kenya.

Philippe Selhorst (P)

Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Jennifer Norman (J)

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Karen Cohen (K)

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Kevin Rebe (K)

Anova Health Institute, Cape Town, South Africa.
Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Carolyn Williamson (C)

Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
National Health Laboratory Service, Johannesburg, South Africa.

Jeffrey R Dorfman (JR)

Division of Immunology, Department of Pathology, University of Cape Town, Anzio Rd, Observatory, Cape Town, 7925, South Africa. jeffrey.dorfman@uct.ac.za.
Division of Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Parow, South Africa. jeffrey.dorfman@uct.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH